Page 229 - Read Online
P. 229

milieu. It is known that chronic inflammation induces   and cognitive side effects of interferon‑alpha therapy. Semin Oncol
           a number of negative consequences in the brain, such   1998;25:39‑47.
           as a high rate of tissue damage and structural changes   11.  Hoyo‑Becerra  C,  Schlaak  JF,  Hermann  DM.  Insights  from
                                                                  interferon‑alpha‑related  depression  for  the  pathogenesis  of
           in several areas, which in turn underlie functional    depression associated with inflammation. Brain Behav Immun
           impairments in neurotransmission. These alterations    2014;42:222‑31.
           underpin some kind of both neuroanatomical and     12.  Schaefer M, Engelbrecht MA, Gut O, Fiebich BL, Bauer J, Schmidt F,
                                                                  Grunze H, Lieb K. Interferon alpha (IFNalpha) and psychiatric
           neurophysiological "vulnerability" in BD and represent   syndromes: a review. Prog Neuropsychopharmacol Biol Psychiatry
           the biological substrate for further relapses and      2002;26:731‑46.
           progression of the illness.                        13.  Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A,
                                                                  Pollmacher  T. Cytokine‑associated emotional and cognitive
                                                                  disturbances in humans. Arch Gen Psychiatry 2001;58:445‑52.
           Clinical observations indicate that BD is, in fact, a   14.  Maes M. Evidence for an immune response in major depression: a
           progressive disease, with many recurrences leading     review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry
           to more and more frequent and severe relapses,         1995;19:11‑38.
           and associated with a reduction of inter‑episode   15.  Danner M, Kasl SV, Abramson JL, Vaccarino V. Association between
           duration time, cognitive decline, and a worsening      depression and elevated C‑reactive protein.  Psychosom Med
                                                                  2003;65:347‑56.
           of the response to treatment, both pharmacological   16.  Ford DE, Erlinger TP. Depression and C‑reactive protein in US adults:
           and psychotherapeutic. [227‑232]  This ongoing process   data from the Third National Health and Nutrition Examination
           is likely to be exacerbated during acute phases of     Survey. Arch Intern Med 2004;164:1010‑4.
           the illness, especially excitatory phases, and might   17.  Kuo HK, Yen CJ, Chang CH, Kuo CK, Chen JH, Sorond F. Relation
                                                                  of C‑reactive protein to stroke, cognitive disorders, and depression
           be due, at least in part, to a stronger activation of the   in the general population: systematic review and meta‑analysis.
           inflammatory system. [233,234]  Drugs modulating the   Lancet Neurol 2005;4:371‑80.
           immune system, or specifically some of its components,   18.  Levine J, Barak Y, Chengappa KN, Rapoport A, Rebey M, Barak V.
                                                                  Cerebrospinal cytokine levels in patients with acute depression.
           currently represent a promising field of investigation   Neuropsychobiology 1999;40:171‑6.
           toward the development of add‑on therapies aimed to   19.  Maes M. Major depression and activation of the inflammatory
           achieve better clinical outcomes in the treatment of BD.  response system. Adv Exp Med Biol 1999;461:25‑46.
                                                              20.  Owen BM, Eccleston D, Ferrier IN, Young AH. Raised levels of
                                                                  plasma interleukin‑1beta in major and postviral depression. Acta
           Financial support and sponsorship                      Psychiatr Scand 2001;103:226‑8.
           This study was part of the FIRB project code       21.  Frick  LR, Williams  K, Pittenger  C. Microglial dysregulation in
           RBFR12LD0W_002 and has been funded by a grant of       psychiatric disease. Clin Dev Immunol 2013;2013:608654.
           the Italian Ministry of Research.                  22.  Steiner J, Bogerts B, Sarnyai Z, Walter M, Gos T, Bernstein HG,
                                                                  Myint AM. Bridging the gap between the immune and glutamate
                                                                  hypotheses of schizophrenia and major depression: potential role of
           Conflicts of interest                                  glial NMDA receptor modulators and impaired blood‑brain barrier
           There are no conflicts of interest.                    integrity. World J Biol Psychiatry 2012;13:482‑92.
                                                              23.  Tham MW, Woon PS, Sum MY, Lee TS, Sim K. White matter
           REFERENCES                                             abnormalities in major depression: evidence from post‑mortem,
                                                                  neuroimaging and genetic studies. J Affect Disord 2011;132:26‑36.
                                                              24.  Black  CN, Bot  M, Scheffer  PG, Cuijpers  P, Penninx  BW. Is
           1.   Miller AH, Manji HK. On redefining the role of the immune system   depression associated with increased oxidative stress? A
              in psychiatric disease. Biol Psychiatry 2006;60:796‑8.  systematic review and meta‑analysis. Psychoneuroendocrinology
           2.   Najjar  S,  Pearlman  DM,  Alper  K,  Najjar  A,  Devinsky  O.   2015;51:164‑75.
              Neuroinflammation and psychiatric illness. J Neuroinflammation   25.  Leonard B, Maes M. Mechanistic explanations how cell‑mediated
              2013;10:43.                                         immune activation, inflammation and oxidative and nitrosative
           3.   Rosenblat  JD, Cha  DS, Mansur  RB, McIntyre  RS. Inflamed   stress pathways and their sequels and concomitants play a role in
              moods: a review of the interactions between inflammation and   the pathophysiology of unipolar depression. Neurosci Biobehav Rev
              mood disorders.  Prog Neuropsychopharmacol Biol Psychiatry   2012;36:764‑85.
              2014;53:23‑34.                                  26.  Lopresti  AL, Maker  GL, Hood  SD, Drummond  PD. A  review
           4.   Cavanagh J, Mathias C. Inflammation and its relevance to psychiatry.   of peripheral biomarkers in major depression: the potential
              Adv Psychiatr Treat 2008;14:248‑55.                 of inflammatory and oxidative stress biomarkers.  Prog
           5.   Yirmiya R. Depression in medical illness: the role of the immune   Neuropsychopharmacol Biol Psychiatry 2014;48:102‑11.
              system. West J Med 2000;173:333‑6.              27.  Michel TM, Pulschen D, Thome J. The role of oxidative stress in
           6.   Kent S, Bluthe RM, Kelley KW, Dantzer R. Sickness behavior as a new   depressive disorders. Curr Pharm Des 2012;18:5890‑9.
              target for drug development. Trends Pharmacol Sci 1992;13:24‑8.  28.  Beumer W, Gibney SM, Drexhage RC, Pont‑Lezica L, Doorduin J,
           7.   Dantzer R. Cytokine‑induced sickness behavior: mechanisms and   Klein  HC,  Steiner  J, Connor  TJ,  Harkin  A, Versnel  MA,
              implications. Ann N Y Acad Sci 2001;933:222‑34.     Drexhage HA. The immune theory of psychiatric diseases: a key
           8.   Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW.   role for activated microglia and circulating monocytes. J Leukoc
              From inflammation to sickness and depression: when the immune   Biol 2012;92:959‑75.
              system subjugates the brain. Nat Rev Neurosci 2008;9:46‑56.  29.  Roman A, Kreiner G, Nalepa I. Macrophages and depression‑a
           9.   Janssen HL, Brouwer JT, van der Mast RC, Schalm SW. Suicide   misalliance or well‑arranged marriage?  Pharmacol Rep
              associated with alfa‑interferon therapy for chronic viral hepatitis.   2013;65:1663‑72.
              J Hepatol 1994;21:241‑3.                        30.  Smith RS. The macrophage theory of depression. Med Hypotheses
           10.  Valentine AD, Meyers CA, Kling MA, Richelson E, Hauser P. Mood   1991;35:298‑306.



          Neuroimmunol Neuroinflammation | Volume 2 | Issue 4 | October 15, 2015                            221
   224   225   226   227   228   229   230   231   232   233   234